Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Changes in Stockholders' Equity

v3.23.2
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
 12 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Special Voting | 2020 notes    
Statement    
Conversion of promissory notes   $ 0
Special Voting | 2021 notes    
Statement    
Conversion of promissory notes   0
Special Voting    
Statement    
Balance beginning of period $ 0 $ 0
Balance beginning of period (in shares)   1
Share compensation expense 0 $ 0
Conversion of promissory notes (in shares)   1
Shares issued in lieu of liabilities 0 $ 0
Options exercised in conjunction with 2021 Notes   0
Foreign Currency translation 0 0
Net loss 0 0
Balance at end of period $ 0 0
Balance at end of period (in shares) 1  
Common Shares | Common Shares | 2020 notes    
Statement    
Conversion of promissory notes   $ 1,408
Conversion of promissory notes (in shares)   1
Common Shares | Common Shares | 2021 notes    
Statement    
Conversion of promissory notes   $ 946,194
Shares issued in lieu of liabilities (In shares)   946
Common Shares | Common Shares    
Statement    
Balance beginning of period $ 6,879,554 $ 5,701,815
Balance beginning of period (in shares)   5,702
Share compensation expense $ 0 $ 0
Share compensation expense (in shares) 0 0
Conversion of promissory notes (in shares)   6,879
Shares issued in lieu of liabilities $ 110,000 $ 50,000
Shares issued for in lieu of services (in shares) 110  
Cancellation of notes by shareholders (in shares)   50
Options exercised in conjunction with 2021 Notes   $ 180,137
Options exercised in conjunction with 2021 Notes (in shares)   180
Foreign Currency translation $ 0 $ 0
Net loss 0 0
Balance at end of period $ 6,989,554 6,879,554
Balance at end of period (in shares) 6,989  
Additional Paid in Capital | 2020 notes    
Statement    
Conversion of promissory notes   (924)
Additional Paid in Capital | 2021 notes    
Statement    
Conversion of promissory notes   8,987,888
Additional Paid in Capital    
Statement    
Balance beginning of period $ 98,294,558 88,227,506
Share compensation expense 308,305 384,365
Shares issued in lieu of liabilities 68,090 53,750
Options exercised in conjunction with 2021 Notes   641,973
Balance at end of period 98,670,953 98,294,558
Accumulated Deficit | 2020 notes    
Statement    
Conversion of promissory notes   0
Accumulated Deficit | 2021 notes    
Statement    
Conversion of promissory notes   0
Accumulated Deficit    
Statement    
Balance beginning of period (95,402,321) (84,994,327)
Share compensation expense 0 0
Shares issued in lieu of liabilities 0 0
Options exercised in conjunction with 2021 Notes   0
Foreign Currency translation 0 0
Net loss (4,946,024) (10,407,994)
Balance at end of period (100,348,345) (95,402,321)
Accumulated Other Comprehensive Income | 2020 notes    
Statement    
Conversion of promissory notes   0
Accumulated Other Comprehensive Income | 2021 notes    
Statement    
Conversion of promissory notes   0
Accumulated Other Comprehensive Income    
Statement    
Balance beginning of period 28,096 42,149
Share compensation expense 0 0
Shares issued in lieu of liabilities 0 0
Options exercised in conjunction with 2021 Notes   0
Foreign Currency translation 1,719 (14,053)
Net loss 0 0
Balance at end of period 29,815 28,096
2020 notes    
Statement    
Conversion of promissory notes   (923)
2021 notes    
Statement    
Conversion of promissory notes   8,988,834
Balance beginning of period 2,927,212 3,281,030
Share compensation expense 308,305 384,365
Shares issued in lieu of liabilities $ 68,200 $ 53,800
Shares issued for in lieu of services (in shares) 110,000 50,000
Options exercised in conjunction with 2021 Notes   $ 642,153
Foreign Currency translation $ 1,719 (14,053)
Net loss (4,946,024) (10,407,994)
Balance at end of period $ (1,640,588) $ 2,927,212